Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Benchmark Holdings LSE:BMK London Ordinary Share GB00BGHPT808 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00p -2.15% 45.50p 43.00p 48.00p - - - 0 07:30:02
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 151.5 -13.7 -0.9 - 253.88

Benchmark Holdings PLC Posting of Annual Report & Notice of AGM

29/01/2019 3:07pm

UK Regulatory (RNS & others)


Benchmark Holdings (LSE:BMK)
Historical Stock Chart

3 Months : From Jan 2019 to Apr 2019

Click Here for more Benchmark Holdings Charts.

TIDMBMK

RNS Number : 4452O

Benchmark Holdings PLC

29 January 2019

29 January 2019

BENCHMARK HOLDINGS PLC

("Benchmark" or the "Company")

Posting of Annual Report & Accounts and Notice of AGM

Benchmark (AIM: BMK), the aquaculture health, nutrition and genetics business, announces that its Annual Report and Accounts for the year ended 30 September 2018 and the notice of the 2019 Annual General Meeting ("AGM") and related form of proxy have been posted to shareholders.

The AGM will be held on 14 March 2019 at 12:00pm at Travers Smith LLP, 10 Snow Hill, London, EC1A 2AL.

An electronic copy of the Annual Report and Accounts is available in the Investor Relations section of the Company's website, www.benchmarkplc.com/investors/

Enquiries

For further information, please contact:

   Benchmark Holdings plc                                              Tel: 020 3915 1236 

Malcolm Pye, CEO

Ivonne Cantu, Investor Relations Director

Numis Tel: 020 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

James Black (Corporate Broking)

MHP Tel: 020 3128 8742

   Katie Hunt / Reg Hoare /Alistair de Kare-Silver      benchmark@mphc.com 

Notes to Editors:

Benchmark's mission is to drive sustainability in food production. We are a leading provider of aquaculture solutions in genetics, health and specialist nutrition. Our focus is on developing innovative products that help fish and shrimp producers improve their sustainability and profitability by improving yield, quality, health and welfare. Our main products are salmon eggs with superior genetic traits, specialist nutrition products for shrimp and fish, and health treatments including a sea lice treatment for salmon. We serve all the major aquaculture markets around the world and have leading market positions. Benchmark operates in 27 countries, employs 1,066 people and reported revenues of GBP151.5m in FY 2018.

For further information on Benchmark please visit www.benchmarkplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ACSPGUGUGUPBGAB

(END) Dow Jones Newswires

January 29, 2019 10:07 ET (15:07 GMT)

1 Year Benchmark Holdings Chart

1 Year Benchmark Holdings Chart

1 Month Benchmark Holdings Chart

1 Month Benchmark Holdings Chart
Your Recent History
LSE
BMK
Benchmark ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190424 06:48:35